News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Bellemin Jean-Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 168,750 options to buy
@ $7.12, valued at
$1.2M
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 135,000 options to buy
@ $15.49, valued at
$2.1M
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Bellemin Jean-Marc (CFO) has filed a Form 4 on IOVANCE BIOTHERAPEUTICS, INC.|
Txns:
| Granted 150,000 options to buy
@ $50.26, valued at
$7.5M
|
|
| 12/17/2020 |
3
| Bellemin Jean-Marc (CFO) has filed a Form 3 on IOVANCE BIOTHERAPEUTICS, INC. |
| 02/27/2020 |
4
| Bellemin Jean-Marc (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 110,000 options to buy
@ $8.91, valued at
$980.1k
|
|
| 03/14/2019 |
4
| Bellemin Jean-Marc (See Remarks) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 66,000 options to buy
@ $12.02, valued at
$793.3k
|
|
| 09/27/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|